20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T8326 | BMS-2 | VEGFR , FLT , c-Met/HGFR | |
BMS-2 is a Met/Flt-3/VEGFR2 tyrosine kinase inhibitor. | |||
T2610L | BMS-599626 2HCL(714971-09-2 Free base) | BMS 599626 dihydrochloride,BMS-599626 2HCL(714971-09-2 Free base),AC480 2HCl | HER |
BMS-599626 2HCL (AC480 2HCl) is a BMS-599626 derivative. BMS-599626 is an orally available and selective dual inhibitor of HER1 and HER2 with IC50s of 20 and 30 nM, respectively. BMS-599626 inhibits tumor cell proliferat... | |||
T14688 | BMS CCR2 22 | CCR | |
BMS CCR2 22 is a potent and selective antagonist of CCR2 with calcium flux IC50 of 18 nM, chemotaxis IC50 of 1 nM, and binding IC50 of 5.1 nM. | |||
T3146 | BMS-202 | PD1-PDL1 inhibitor 2,PD-1/PD-L1 inhibitor 2 | Apoptosis , PD-1/PD-L1 |
BMS-202 (PD1-PDL1 inhibitor 2) is an inhibitor of the PD-1 (Programmed death- 1) /PD-Ll (Programmed death-ligand 1) protein/protein interaction. | |||
T6418 | BMS-378806 | BMS378806,BMS-806 | gp120/CD4 , HIV Protease |
BMS-378806 (BMS-806) selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus. | |||
T7309 | TAS-103 dihydrochloride | TAS-103 (dihydrochloride),BMS-247615 dihydrochloride | Topoisomerase |
TAS-103 dihydrochloride (BMS-247615 dihydrochloride) is a novel anticancer agent targeting both topoisomerase (Topo) I and Topo II. | |||
T6420 | BMS-707035 | HIV Protease | |
BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM. Phase 2. | |||
T7787 | BMS817378 | c-Met/HGFR | |
BMS817378 is a potent and selective inhibitor of MET(IC50 : 1.7 nM). | |||
T4696 | BMS202 hydrochloride (1675203-84-5(free base)) | PD-1/PD-L1 inhibitor 2 hydrochloride | PD-1/PD-L1 |
BMS202 hydrochloride (1675203-84-5(free base)) (PD-1/PD-L1 inhibitor 2 hydrochloride) is a small-molecule PD-1/PD-L1 interaction inhibitor (IC50: 18 nM). Biophysical studies demonstrate that BMS202 binds directly to PD-L... | |||
T71394 | BMS-823778 | ||
BMS-823778 is an orally available potent and selective inhibitor of 11-β-hydroxysteroid-dehydrogenase 1 (11βHSD-1). BMS-823778 is a potential therapeutic agent for type 2 diabetes mellitus (T2DM). | |||
T2679 | BMS-265246 | BMS265246 | CDK |
BMS-265246 is a potent and selective CDK1/2 inhibitor. | |||
T6249 | Avagacestat | BMS-708163 | Gamma-secretase |
Avagacestat (BMS-708163) (BMS-708163) is a potent, selective, orally bioavailable γ-secretase inhibitor of Aβ40 and Aβ42 with IC50 of 0.3 nM and 0.27 nM, demonstrating a 193-fold selectivity against Notch. Phase 2. | |||
T2389 | Dapagliflozin | BMS-512148 | SGLT , HIF |
Dapagliflozin (BMS-512148) is a selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity. | |||
T26852 | BMS-605541 | BMS605541,BMS 605541 | VEGFR |
BMS-605541 is a potent and selective inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) kinase activity(Ki=49 nM). | |||
T39789 | BMS-986235 | BMS-986235,LAR-1219 | Others |
BMS-986235 (LAR-1219) is a selective and orally active agonist of formyl peptide receptor 2 (FPR2) with EC50s of 0.41 nM and 3.4 nM for hFPR2 and mFPR2, respectively. BMS-986235 can be used in studies about the preventio... | |||
T6297 | Alvespimycin hydrochloride | BMS 826476,NSC 707545,KOS-1022,17-DMAG hydrochloride,Alvespimycin (17-DMAG) HCl | Apoptosis , HSP |
Alvespimycin hydrochloride (BMS 826476) is a potent HSP90 inhibitor with IC50 of 62 nM. Phase 2. | |||
T22049 | BMS 753 | Retinoid Receptor | |
BMS 753 is an agonist of isotype-selective retinoic acid receptor α (RARα, Ki= 2 nM). | |||
T6419 | BMS-536924 | HY-10262,BMS 536924,CS-0117 | Apoptosis , FAK , MEK , IGF-1R , Src |
BMS-536924 (BMS 536924) is an ATP-competitive IGF-1R/IR inhibitor with IC50 of 100 nM/73 nM, modest activity for Mek, Fak, and Lck with very little activity for Akt1, MAPK1/2. | |||
T14680 | BMS-906024 | Osugacestat,AL-101,BM-0018 | Gamma-secretase |
BMS-906024 (Osugacestat) is an orally available and selective inhibitor of γ-secretase, a small molecule Notch inhibitor.BMS-906024 has broad-spectrum antitumour activity against a variety of human cancer xenografts.BMS-... | |||
T4532 | Linrodostat | BMS-986205 | IDO , Indoleamine 2,3-Dioxygenase (IDO) |
Linrodostat (BMS-986205) is a selective indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitor. |